- Home
- Life Sciences
- Pharmaceutical
- Pathology
- Pathology Analysis & Statistics, May 2013 (p20)
Talk to Robyn
(866) 682 9815
Search inside this page
Top countries
- United States (3 955)
- World (47 550)
- Japan (2 630)
- France (2 537)
- Germany (2 528)
-
- Europe (541)
- Spain (2 512)
- United Kingdom (2 494)
- Italy (2 523)
- China (2 438)
- India (2 391)
- Canada (2 195)
- Australia (2 155)
- Sweden (2 019)
- South Korea (2 355)
- Denmark (2 009)
- Singapore (2 167)
- Norway (2 006)
- Switzerland (2 053)
- Indonesia (2 294)
Publication dates
Publishers
- Global Data (1 509)
- Global Markets Direct (1 838)
- Bioseeker (243)
- Euromonitor International (24)
- Ibisworld (8)
-
- BCC Research (40)
- Daedal Research (2)
- Firstword Pharma (7)
- KnowMade (2)
- World Market Intelligence Ltd (18)
- Asianet-Pakistan (4)
- Currentpartnering (97)
- GBI Research (40)
- Global Industry Analysts (1)
- International Market Analysis Research and Consult (11)
- La Merie Publishing (31)
- MarketLine (41)
- Transparency Market Research (1)
- TriMark Publications (7)
- Business Monitor International (401 825)
- Datamonitor (316)
- Life Science Analytics (LSA) (61)
- Global Research & Data Services (55)
- ICD Research (47)
- Frost & Sullivan (44)
- Timely Data Resources Inc. (41)
- Visiongain (32)
- Global Industry Analyst (28)
- Espicom Business Intelligence (27)
- Business Review (23)
- ABMRG (22)
- The Assessment Group (19)
- Kalorama Information (17)
- SCRIP Insights (17)
- Koncept Analytics (15)
- Asia Market Information & Development Company (14)
- CHI Insight Pharma Reports (14)
- Apollo Managed Care Consultants (13)
- Infiniti Research Limited (9)
- Sociable Pharma (9)
- IData Research, Inc. (9)
- Grey House Publishing (7)
- RNCOS (6)
- BioPharm Reports (5)
- MarketsandMarkets (5)
- Venture Planning Group (5)
- Aruvian's R'search (4)
- Freedonia (4)
- Canadean Ltd (3)
- Netscribes (India) Pvt. Ltd. (3)
- Renub Research (3)
- Arrowhead (2)
- France Innovation Scientifique et Transfert (2)
- Greystone Research Associates (2)
- Packaged Facts (2)
- Urch Publishing (2)
- Barnes Reports (1)
- Cygnus Business Consulting and Research (1)
- Ken Research Private (1)
- PMR Ltd. (1)
- Red Mountain Insights (1)
- Research In China (1)
- VacZine Analytics Group Of Assay Advantage Ltd (1)
- Verdict Research Ltd (1)
- WinterGreen Research (1)
- Zzz FACT Research (1)
All regions
-
- Algeria (2 248)
- Angola (2 320)
- Benin (2 312)
- Botswana (2 225)
- Burkina Faso (2 294)
- Burundi (2 306)
- Cameroon (2 318)
- Cape Verde (2 243)
- Central African Republic (106)
- Chad (2 313)
- Comoros (2 099)
- Congo, Democratic Republic Of (2 505)
- Djibouti (2 289)
- Egypt (2 338)
- Equatorial Guinea (2 292)
- Eritrea (2 259)
- Ethiopia (2 297)
- Gabon (2 269)
- Gambia (2 277)
- Ghana (2 321)
- Guinea (6 871)
- Guinea Bissau (2 303)
- Kenya (2 294)
- Lesotho (2 130)
- Liberia (2 210)
- Libyan Arab Jamahiriya (2 235)
- Madagascar (2 268)
- Malawi (2 309)
- Mali (2 318)
- Mauritania (2 262)
- Mauritius (2 206)
- Morocco (2 311)
- Mozambique (2 290)
- Namibia (2 221)
- Niger (2 318)
- Nigeria (2 327)
- Rwanda (2 281)
- Sao Tome and Principe (1 956)
- Senegal (2 315)
- Seychelles (2 063)
- Sierra Leone (2 307)
- Somalia (2 231)
- South Africa (2 267)
- Sudan (2 336)
- Swaziland (2 206)
- Tanzania (2 290)
- Togo (2 309)
- Tunisia (2 236)
- Uganda (2 320)
- Zambia (2 289)
- Zimbabwe (2 288)
-
- Afghanistan (2 321)
- Armenia (2 178)
- Azerbaijan (2 186)
- Bahrain (2 030)
- Bangladesh (2 288)
- Bhutan (2 207)
- Brunei Darussalam (2 078)
- Cambodia (2 300)
- China (2 438)
- Georgia (2 084)
- India (2 391)
- Indonesia (2 294)
- Iran (2 223)
- Iraq (2 315)
- Israel (2 034)
- Japan (2 630)
- Jordan (2 146)
- Kazakhstan (2 118)
- Kuwait (2 116)
- Kyrgyz Republic (kyrgyzstan) (2 187)
- Laos (2 295)
- Lebanon (1 553)
- Malaysia (2 290)
- Maldives (2 199)
- Mongolia (99)
- Myanmar (2 260)
- Nepal (2 280)
- North Korea (119)
- Oman (2 189)
- Pakistan (2 300)
- Philippines (2 300)
- Qatar (2 012)
- Saudi Arabia (2 234)
- Singapore (2 167)
- South Korea (2 355)
- Sri Lanka (2 254)
- Syrian Arab Republic (2 188)
- Taiwan (19)
- Tajikistan (2 163)
- Thailand (2 292)
- Turkey (4)
- Turkmenistan (98)
- United Arab Emirates (2 142)
- Uzbekistan (2 189)
- Vietnam (2 311)
- Yemen (2 334)
-
- Albania (2 040)
- Andorra (1 425)
- Austria (2 030)
- Belarus (2 055)
- Belgium (2 052)
- Bosnia and Herzegovina (2 028)
- Bulgaria (2 053)
- Croatia (2 006)
- Cyprus (1 986)
- Czech Republic (2 008)
- Denmark (2 009)
- Estonia (1 966)
- Finland (1 993)
- France (2 537)
- Germany (2 528)
- Greece (2 087)
- Hungary (2 039)
- Iceland (1 904)
- Ireland (2 032)
- Italy (2 523)
- Latvia (2 017)
- Lithuania (2 087)
- Luxembourg (1 932)
- Macedonia (91)
- Malta (1 990)
- Moldova, Republic Of (2 023)
- Monaco (1 268)
- Netherlands (2 052)
- Norway (2 006)
- Poland (2 080)
- Portugal (2 110)
- Romania (2 068)
- Russian Federation (2 148)
- San Marino (1 114)
- Serbia and Montenegro (2 060)
- Slovakia (slovak Republic) (2 045)
- Slovenia (1 978)
- Spain (2 512)
- Sweden (2 019)
- Switzerland (2 053)
- Ukraine (2 096)
- United Kingdom (2 494)
-
- Antigua and Barbuda (2 061)
- Bahamas (2 105)
- Barbados (2 101)
- Belize (2 122)
- Canada (2 195)
- Costa Rica (2 185)
- Cuba (2 211)
- Dominica (4 113)
- Dominican Republic (2 285)
- El Salvador (2 220)
- Grenada (2 018)
- Guatemala (2 373)
- Haiti (2 275)
- Honduras (2 317)
- Jamaica (2 169)
- Mexico (2 379)
- Nicaragua (2 265)
- Panama (1 561)
- Saint Kitts & Nevis (1 889)
- Saint Lucia (2 227)
- United States (3 955)
-
- Argentina (2 264)
- Australia (2 155)
- Brazil (2 438)
- Canada (2 195)
- China (2 438)
- France (2 537)
- Germany (2 528)
- India (2 391)
- Indonesia (2 294)
- Italy (2 523)
- Japan (2 630)
- Mexico (2 379)
- Russian Federation (2 148)
- Saudi Arabia (2 234)
- South Africa (2 267)
- South Korea (2 355)
- Turkey (4)
- United Kingdom (2 494)
- United States (3 955)
-
- Australia (2 155)
- Austria (2 030)
- Belgium (2 052)
- Canada (2 195)
- Chile (2 214)
- Czech Republic (2 008)
- Denmark (2 009)
- Estonia (1 966)
- Finland (1 993)
- France (2 537)
- Germany (2 528)
- Greece (2 087)
- Hungary (2 039)
- Iceland (1 904)
- Ireland (2 032)
- Israel (2 034)
- Italy (2 523)
- Japan (2 630)
- Luxembourg (1 932)
- Mexico (2 379)
- Netherlands (2 052)
- New Zealand (1 942)
- Norway (2 006)
- Poland (2 080)
- Portugal (2 110)
- Slovenia (1 978)
- South Korea (2 355)
- Spain (2 512)
- Sweden (2 019)
- Switzerland (2 053)
- Turkey (4)
- United Kingdom (2 494)
- United States (3 955)
data types
Free Market Research Guides to Download
Pathology Analysis & Statistics, May 2013 (p20)
You might be interested in: cancer, breast cancer, prostate cancer, more »
» Purchase Premium Reports
571-610 of about 4 800 reports
Austria Peptic Ulcer Disease, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Austria
Norway Peptic Ulcer Disease, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Norway
Palau Post-traumatic Stress Disorder, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : World
Iraq Prostate Cancer, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Iraq, World
Lesotho Post-traumatic Stress Disorder, 15-29 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Lesotho
Belgium Protein-energy Malnutrition, 70+ Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Belgium
Paraguay Prostate Cancer, 70+ Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Paraguay
Honduras Prostate Cancer, 70+ Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Honduras
Dominican Republic Post-traumatic Stress Disorder, 30-44 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Dominican Republic, Dominica
Papua New Guinea Schistosomiasis, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Papua New Guinea, Guinea
UMN Pharma Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- February 2013
- by Global Data
Summary UMN Pharma Inc. (UMN) is a biopharmaceutical company, based in Japan. The company develops vaccines to cure diabetes, muscular dystrophy and influenza. Its product portfolio includes UMN-0502, ...
- Industries : Pathology
- Countries : Japan
Bristol-Myers Squibb Company : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report
- $ 125
- Company report
- January 2013
- by ICD Research
Synopsis ICD Research's "Bristol-Myers Squibb Company : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report" contains in depth information and data about the company and its operations. ...
- Industries : Pathology
- Countries : United States
Idenix Pharmaceuticals, Inc. : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report
- $ 125
- Company report
- January 2013
- by ICD Research
Synopsis ICD Research's "Idenix Pharmaceuticals, Inc. : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report" contains in depth information and data about the company and its operations. ...
- Industries : Pathology
- Countries : United States
MacroGenics, Inc. SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- January 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pathology
Amyotrophic Lateral Sclerosis - Analysis and Market Forecasts to 2019
- $ 5 995
- Industry report
- January 2013
- by Global Data
Amyotrophic Lateral Sclerosis - Analysis and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, ?Amyotrophic Lateral Sclerosis - Analysis and ...
- Industries : Pathology
- Countries : United States, Japan, United Kingdom, Spain, Italy, France, Germany, Europe, World
Acquired Orphan Blood Diseases Therapeutics Market to 2019 - Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential
- $ 3 500
- Industry report
- January 2013
- by GBI Research
Acquired Orphan Blood Diseases Therapeutics Market to 2019 - Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential Summary GBI Research has released its latest research, ?Acquired ...
- Industries : Pathology
- Countries : Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom
PharmaPoint: HIV - Current and Future Players
- $ 2 995
- Industry report
- January 2013
- by Global Data
PharmaPoint: HIV - Current and Future Players Summary GlobalData has released its pharma report, ?PharmaPoint: HIV - Current and Future Players?. The report is a vital source of up-to-date information ...
- Industries : Pathology
- Countries : Japan, World
The Pharmaceutical Market: Zambia
- $ 1 266
- Industry report
- January 2013
- by Business Monitor International
Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN ZAMBIA The majority of investment in Zambia's healthcare market stems from international ...
- Industries : Pathology
- Countries : Zambia
EpiCast Report: Crohn's Disease Epidemiology Forecast to 2022
- $ 3 995
- Industry report
- January 2013
- by Global Data
EpiCast Report: Crohn's Disease Epidemiology Forecast to 2022 Summary Crohn's disease is a form of inflammatory bowel disease (IBD) characterized by recurrent inflammation of all or part of the gastrointestinal ...
- Industries : Pathology
- Countries : United States, Canada, Japan, India, China, Spain, Italy, France, Germany, World, United Kingdom, Europe, Asia, North America
Cobicistat (HIV) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- January 2013
- by Global Data
Cobicistat (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Cobicistat (HIV) - Forecast and Market Analysis to 2022?. Human I ...
- Industries : Pathology
Dolutegravir (HIV) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- January 2013
- by Global Data
Dolutegravir (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Dolutegravir (HIV) - Forecast and Market Analysis to 2022?. Human ...
- Industries : Pathology
- Countries : World, Brazil, Spain, Italy, France, Germany, Japan, China, United States, Europe, United Kingdom
572-Trii (HIV) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- January 2013
- by Global Data
572-Trii (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?572-Trii (HIV) - Forecast and Market Analysis to 2022?. Human Immunodeficiency ...
- Industries : Pathology
- Countries : World, Brazil, Spain, Italy, France, Germany, Japan, China, United States, Europe, United Kingdom
Quad 2 (HIV) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- January 2013
- by Global Data
Quad 2 (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Quad 2 (HIV) - Forecast and Market Analysis to 2022?. Human Immunodeficiency ...
- Industries : Pathology
- Countries : World, Brazil, Spain, Italy, France, Germany, Japan, China, United States, Europe, United Kingdom
Stribild (HIV) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- January 2013
- by Global Data
Stribild (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Stribild (HIV) - Forecast and Market Analysis to 2022?. Human Immunodeficiency ...
- Industries : Pathology
- Countries : World, Brazil, Spain, Italy, France, Germany, Japan, China, United States, Europe, United Kingdom
Complera (HIV) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- January 2013
- by Global Data
Complera (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Complera (HIV) - Forecast and Market Analysis to 2022?. Human Immunodeficiency ...
- Industries : Pathology
- Countries : World, Brazil, Spain, Italy, France, Germany, Japan, China, United States, Europe, United Kingdom
Atripla (HIV) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- January 2013
- by Global Data
Atripla (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Atripla (HIV) - Forecast and Market Analysis to 2022?. Human Immunodeficiency ...
- Industries : Pathology
- Countries : World, Brazil, Spain, Italy, France, Germany, Japan, China, United States, Europe, United Kingdom
Norvir (HIV) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- January 2013
- by Global Data
Norvir (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Norvir (HIV) - Forecast and Market Analysis to 2022?. Human Immunodeficiency ...
- Industries : Pathology
- Countries : World, Brazil, Spain, Italy, France, Germany, Japan, China, United States, Europe, United Kingdom
Isentress (HIV) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- January 2013
- by Global Data
Isentress (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Isentress (HIV) - Forecast and Market Analysis to 2022?. Human Immunodeficiency ...
- Industries : Pathology
- Countries : World, Brazil, Spain, Italy, France, Germany, Japan, China, United States, Europe, United Kingdom
Truvada (HIV) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- January 2013
- by Global Data
Truvada (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Truvada (HIV) - Forecast and Market Analysis to 2022?. Human Immunodeficiency ...
- Industries : Pathology
- Countries : World, Brazil, Spain, Italy, France, Germany, Japan, China, United States, Europe, United Kingdom
Epzicom (HIV) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- January 2013
- by Global Data
Epzicom (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Epzicom (HIV) - Forecast and Market Analysis to 2022?. Human Immunodeficiency ...
- Industries : Pathology
- Countries : World, Brazil, United States, Spain, Italy, France, Germany, Japan, China, Europe, United Kingdom
Kaletra (HIV) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- January 2013
- by Global Data
Kaletra (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Kaletra (HIV) - Forecast and Market Analysis to 2022?. Human Immunodeficiency ...
- Industries : Pathology
- Countries : Brazil, Japan, China, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom, South America
Reyataz (HIV) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- January 2013
- by Global Data
Reyataz (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Reyataz (HIV) - Forecast and Market Analysis to 2022?. Human Immunodeficiency ...
- Industries : Pathology
- Countries : World, Brazil, Spain, Italy, France, Germany, Japan, China, United States, Europe, United Kingdom
Prezista (HIV) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- January 2013
- by Global Data
Prezista (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Prezista (HIV) - Forecast and Market Analysis to 2022?. Human Immunodeficiency ...
- Industries : Pathology
- Countries : World, Brazil, Spain, Italy, France, Germany, Japan, China, United States, Europe, United Kingdom
Daiichi Sankyo Company, Ltd : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report
- $ 125
- Company report
- January 2013
- by ICD Research
Synopsis ICD Research's "Daiichi Sankyo Company, Ltd : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report" contains in depth information and data about the company and its operations. ...
- Industries : Pathology
- Countries : Japan
Teva Pharmaceutical Industries Limited : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report
- $ 125
- Company report
- January 2013
- by ICD Research
Synopsis ICD Research's "Teva Pharmaceutical Industries Limited : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report" contains in depth information and data about the company and ...
- Industries : Pathology
Resolvyx Pharmaceuticals, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- January 2013
- by Global Data
Summary Resolvyx Pharmaceuticals, Inc (Resolvyx) is a pharmaceutical service provider, based in the US. The company discovers, develops and commercializes resolving therapies for the treatment of inflammatory ...
- Industries : Pathology
- Countries : United States
Pharnext SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- January 2013
- by Global Data
Summary Pharnext SAS (Pharnext) is a bio-pharmaceutical company, based in France. The company discovers, develops and licenses new pharmaceutical treatments. It develops products based on Pleocompounds ...
- Industries : Pathology
- Countries : France
Probiodrug AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- January 2013
- by Global Data
Summary Probiodrug AG (Probiodrug) is a biopharmaceutical company, based in Germany. The company develops small molecule drugs. Its products include inhibitors and ligands that target key enzymes such ...
- Industries : Pathology
- Countries : Germany
Pulmatrix, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- January 2013
- by Global Data
Summary Pulmatrix Inc. (Pulmatrix) is a privately held, clinical stage biopharmaceutical company that discovers and develops novel inhaled therapies for the treatment and prevention of respiratory diseases. ...
- Industries : Pathology
- Countries : United States
Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Theraclone Sciences, Inc.
- $ 250
- Company report
- January 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pathology
- Countries : United States
» Download Public Reports
About 17 000 reports
Company Report: Pathology in The United States and Ireland for Year 2013
- Company report
- May 2013
- 5 pages
- by Corporation
... Involved, even indirectly, with an important therapeutic area that addresses the needs of millions of patients who suffer from respiratory disease is particularly meaningful to all of us at elan." Relvar ...
U.s. Pharmaceutical Industry
May 2013The Swazi Pharmaceutical Industry
May 2013» Read our Company Profiles
About 200 CompaniesGlaxoSmithKline P.L.C.
United StatesNovartis Inc.
SwitzerlandGlaxoSmithKline PLC
United KingdomEli Lilly and Co.
United StatesLilly and Co.
United StatesReportlinker.com © Copyright 2013. All rights reserved.
